President-elect Trump appears to be a politician in a hurry when it comes to staffing his…
Author
admin
-
-
-
-
-
-
-
Investing
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types
by adminRadiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology…
-
-
-